Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models

By |2023-08-24T10:13:33-04:00July 22nd, 2020|

Shukla, G.S., S.C. Pero, Y. Sun, L. Mei, F. Zhang, G. Sholler, and D.N. Krag, Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models. Clin Transl Oncol, 2020 Jul;22(7):1094-1104

Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients

By |2023-08-24T09:24:40-04:00June 24th, 2020|

Izhar S. Batth, Long Dao, Arun Satelli, Abhisek Mitra, Sofia Yi, Hyangsoon Noh, Heming Li, Zachary, Brownlee, Shouhao Zhou, Jeffrey Bond,  Jing Wang,  Jonathan Gill, Giselle S. Sholler, Shulin Li, Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients, Int. J. Cancer., June 2020;1–10.

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma

By |2023-08-24T10:10:02-04:00May 20th, 2020|

Elizabeth C. Lewis, Jacqueline M. Kraveka, William Ferguson, Don Eslin, Valerie I. Brown, Genevieve Bergendahl, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Peter Zage, Jawhar Rawwas, Maria Rich, Elizabeth Lorenzi, Kristine Broglio, Donald Berry, Giselle L. Saulnier Sholler, A subset analysis of a phase II trial evaluating the use of DFMO as [...]

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

By |2023-08-24T10:15:19-04:00September 27th, 2018|

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen Neville, Don Eslin, Valerie Brown, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Nehal S. Parikh, Francis Eshun, Peter Zage, Jawhar Rawwas, Susan Sencer, Debra Pankiewicz, Monique Quinn, Maria Rich, Joseph Junewick, Jacqueline M. Kraveka, Maintenance DFMO Increases Survival in High [...]

Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses

By |2023-08-24T10:28:33-04:00September 14th, 2018|

Shukla GS, Sun YJ, Pero SC, Sholler GS, Krag DN. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.  J Immunol Methods. 2018 Sep;460:51-62

Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

By |2023-08-24T10:35:17-04:00September 25th, 2017|

Cornelius A, Foley J, Bond J, Nagulapally AB, Steinbrecher J, Hendricks WP, Rich M, Yendrembam S, Bergendahl G, Trent JM, Sholler GS, Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma, Front. Pharmacol., Sept 25, 2017, https://doi.org/10.3389/fphar.2017.00652

Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN

By |2023-08-24T10:38:53-04:00June 8th, 2017|

Rich M, Zhao P, Nagulapally A, Bond J, Saulnier Sholler G. Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN, Journal of Cancer Therapy, June 2017, 8, 561-578

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma

By |2023-08-24T10:50:47-04:00April 21st, 2017|

Maser T, Rich M, Hayes D, Zhao P, Nagulapally AB, Bond J, Saulnier Sholler G. Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma, Cancer Med. 2017 Apr 21. doi: 10.1002/cam4.1065. [Epub ahead of print]

Go to Top